Phase II Study on Biweekly Combination Therapy of Gemcitabine plus Carboplatin for the Treatment of Elderly Patients with Advanced Non‐Small Cell Lung Cancer

Lessons Learned The biweekly GEM plus CBDCA dose and schedule showed satisfactory efficacy with mild toxicities in elderly patients with advanced NSCLC. The biweekly GEM plus CBDCA regimen could be considered an alternative to the 3‐week regimen in NSCLC. Background The gemcitabine (GEM)‐carboplatin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The oncologist (Dayton, Ohio) Ohio), 2020-03, Vol.25 (3), p.208-e417
Hauptverfasser: Takayama, Koichi, Ichiki, Masao, Matsumoto, Takemasa, Ebi, Noriyuki, Akamine, Shinji, Tokunaga, Shoji, Yamada, Tadaaki, Uchino, Junji, Nakanishi, Yoichi
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!